{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:29:05Z","timestamp":1759159745437},"reference-count":50,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            WHO type III nasopharyngeal carcinoma (NPC) is highly prevalent in Indonesia and 100% associated with Epstein-Barr virus (EBV). NPC tumor cells express viral proteins, including BARF1, which is secreted and is considered to have oncogenic and immune-modulating properties. Recently, we found conserved mutations in the BARF1 gene in NPC isolates. This study describes the expression and purification of NPC-derived BARF1 and analyzes humoral immune responses against prototype BARF1 (B95-8) and purified native hexameric BARF1 in sera of Indonesian NPC patients (\n            <jats:italic>n<\/jats:italic>\n            = 155) compared to healthy EBV-positive (\n            <jats:italic>n<\/jats:italic>\n            = 56) and EBV-negative (\n            <jats:italic>n<\/jats:italic>\n            = 16) individuals. BARF1 (B95-8) expressed in\n            <jats:italic>Escherichia coli<\/jats:italic>\n            and baculovirus, as well as BARF1-derived peptides, did not react with IgG or IgA antibodies in NPC. Purified native hexameric BARF1 protein isolated from culture medium was used in enzyme-linked immunosorbent assay (ELISA) and revealed relatively weak IgG and IgA responses in human sera, although it had strong antibody responses to other EBV proteins. Higher IgG reactivity was found in NPC patients (\n            <jats:italic>P<\/jats:italic>\n            = 0.015) than in regional Indonesian controls or EBV-negative individuals (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.001). IgA responses to native BARF1 were marginal. NPC sera with the highest IgG responses to hexameric BARF1 in ELISA showed detectable reactivity with denatured BARF1 by immunoblotting. In conclusion, BARF1 has low immunogenicity for humoral responses and requires native conformation for antibody binding. The presence of antibodies against native BARF1 in the blood of NPC patients provides evidence that the protein is expressed and secreted as a hexameric protein in NPC patients.\n          <\/jats:p>","DOI":"10.1128\/cvi.00193-10","type":"journal-article","created":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T05:50:24Z","timestamp":1291269024000},"page":"298-304","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["Purified Hexameric Epstein-Barr Virus-Encoded BARF1 Protein for Measuring Anti-BARF1 Antibody Responses in Nasopharyngeal Carcinoma Patients"],"prefix":"10.1128","volume":"18","author":[{"given":"E. K.","family":"Hoebe","sequence":"first","affiliation":[{"name":"VU University Medical Center, Department of Pathology, Amsterdam, Netherlands"},{"name":"Gadjah Mada University, Yogyakarta, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. H.","family":"Hutajulu","sequence":"additional","affiliation":[{"name":"VU University Medical Center, Department of Pathology, Amsterdam, Netherlands"},{"name":"Gadjah Mada University, Yogyakarta, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"van Beek","sequence":"additional","affiliation":[{"name":"VU University Medical Center, Department of Pathology, Amsterdam, Netherlands"},{"name":"Gadjah Mada University, Yogyakarta, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Stevens","sequence":"additional","affiliation":[{"name":"VU University Medical Center, Department of Pathology, Amsterdam, Netherlands"},{"name":"Gadjah Mada University, Yogyakarta, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. K.","family":"Paramita","sequence":"additional","affiliation":[{"name":"VU University Medical Center, Department of Pathology, Amsterdam, Netherlands"},{"name":"Gadjah Mada University, Yogyakarta, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Greijer","sequence":"additional","affiliation":[{"name":"VU University Medical Center, Department of Pathology, Amsterdam, Netherlands"},{"name":"Gadjah Mada University, Yogyakarta, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Middeldorp","sequence":"additional","affiliation":[{"name":"VU University Medical Center, Department of Pathology, Amsterdam, Netherlands"},{"name":"Gadjah Mada University, Yogyakarta, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.5.2689-2697.1992"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","volume":"15","year":"2006","unstructured":"Chang, E. T., and H. O. Adami. 2006. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev. 15:1765-1777.","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_3_2_4_2","first-page":"1265","volume":"27","year":"2005","unstructured":"Chang, M. S., et al. 2005. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas. Int. J. Oncol. 27:1265-1272.","journal-title":"Int. J. Oncol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.9.7627-7632.1999"},{"key":"e_1_3_2_6_2","first-page":"5584","volume":"60","year":"2000","unstructured":"Decaussin, G., F. Sbih-Lammali, M. de Turenne-Tessier, A. Bouguermouh, and T. Ooka. 2000. Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res. 60:5584-5588.","journal-title":"Cancer Res."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0168-1702(97)00101-9","volume":"52","year":"1997","unstructured":"de Turenne-Tessier, M., P. Jolicoeur, and T. Ooka. 1997. Expression of the protein encoded by Epstein-Barr virus (EBV) BARF1 open reading frame from a recombinant adenovirus system. Virus Res. 52:73-85.","journal-title":"Virus Res."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1099\/vir.0.83058-0","volume":"88","year":"2007","unstructured":"de Turenne-Tessier, M., and T. Ooka. 2007. Post-translational modifications of Epstein Barr virus BARF1 oncogene-encoded polypeptide. J. Gen. Virol. 88:2656-2661.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.4.1459-1467.2006"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/421245","volume":"190","year":"2004","unstructured":"Fachiroh, J., et al. 2004. Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. J. Infect. Dis. 190:53-62.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ijc.2910420305","volume":"42","year":"1988","unstructured":"F\u00e5hraeus, R., et al. 1988. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int. J. Cancer 42:329-338.","journal-title":"Int. J. Cancer"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0042-6822(88)90546-6","volume":"164","year":"1988","unstructured":"Hatfull, G., A. T. Bankier, B. G. Barrell, and P. J. Farrell. 1988. Sequence analysis of Raji Epstein-Barr virus DNA. Virology 164:334-340.","journal-title":"Virology"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/mp.52.2.97","volume":"52","year":"1999","unstructured":"Hayes, D. P., et al. 1999. Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases. Mol. Pathol. 52:97-103.","journal-title":"Mol. Pathol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1158\/1078-0432.CCR-06-2945","volume":"13","year":"2007","unstructured":"Houali, K., et al. 2007. A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin. Cancer Res. 13:4993-5000.","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-9378-5-16","volume":"5","year":"2010","unstructured":"Hutajulu, S. H., et al. 2010. Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma. Infect. Agents Cancer 5:16.","journal-title":"Infect. Agents Cancer"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archotol.126.11.1329","volume":"126","year":"2000","unstructured":"Jayasurya, A., B. H. Bay, W. M. Yap, and N. G. Tan. 2000. Lymphocytic infiltration in undifferentiated nasopharyngeal cancer. Arch. Otolaryngol. Head Neck Surg. 126:1329-1332.","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1073\/pnas.71.12.4737","volume":"71","year":"1974","unstructured":"Klein, G., et al. 1974. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc. Natl. Acad. Sci. U. S. A. 71:4737-4741.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"e1122","DOI":"10.1371\/journal.pone.0001122","volume":"2","year":"2007","unstructured":"Li, J., et al. 2007. Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy. PLoS One 2:e1122.","journal-title":"PLoS One"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/ijc.23621","volume":"123","year":"2008","unstructured":"Martorelli, D., et al. 2008. Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy. Int. J. Cancer 123:1100-1107.","journal-title":"Int. J. Cancer"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ijc.10309","volume":"99","year":"2002","unstructured":"Meij, P., et al. 2002. Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2. Int. J. Cancer 99:93-99.","journal-title":"Int. J. Cancer"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1086\/314704","volume":"179","year":"1999","unstructured":"Meij, P., et al. 1999. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases. J. Infect. Dis. 179:1108-1115.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0166-0934(00)00233-0","volume":"90","year":"2000","unstructured":"Meij, P., M. B. Vervoort, C. J. Meijer, E. Bloemena, and J. M. Middeldorp. 2000. Production monitoring and purification of EBV encoded latent membrane protein 1 expressed and secreted by recombinant baculovirus infected insect cells. J. Virol. Methods 90:193-204.","journal-title":"J. Virol. Methods"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1040-8428(02)00078-1","volume":"45","year":"2003","unstructured":"Middeldorp, J. M., A. A. Brink, A. J. van den Brule, and C. J. Meijer. 2003. Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit. Rev. Oncol. Hematol. 45:1-36.","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0166-0934(88)90060-2","volume":"21","year":"1988","unstructured":"Middeldorp, J. M., and P. Herbrink. 1988. Epstein-Barr virus specific marker molecules for early diagnosis of infectious mononucleosis. J. Virol. Methods 21:133-146.","journal-title":"J. Virol. Methods"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0166-0934(88)90061-4","volume":"21","year":"1988","unstructured":"Middeldorp, J. M., and R. H. Meloen. 1988. Epitope-mapping on the Epstein-Barr virus major capsid protein using systematic synthesis of overlapping oligopeptides. J. Virol. Methods 21:147-159.","journal-title":"J. Virol. Methods"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.61.2.570-578.1987"},{"key":"e_1_3_2_27_2","first-page":"250","volume":"25","year":"2006","unstructured":"Ng, M. H., K. H. Chan, S. P. Ng, and Y. S. Zong. 2006. Epstein-Barr virus serology in early detection and screening of nasopharyngeal carcinoma. Ai Zheng 25:250-256.","journal-title":"Ai Zheng"},{"key":"e_1_3_2_28_2","first-page":"613","year":"2005","unstructured":"Ooka, T. 2005. Biological role of the BARF1 gene encoded by Epstein-Barr virus, p. 613. In E. S. Robertson (ed.), Epstein-Barr virus. Caister Academic Press, Wymondham, England.","journal-title":"Epstein-Barr virus"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/jmv.20987","volume":"79","year":"2007","unstructured":"Paramita, D. K., et al. 2007. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma. J. Med. Virol. 79:1710-1721.","journal-title":"J. Med. Virol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1044579X0200086X","volume":"12","year":"2002","unstructured":"Raab-Traub, N. 2002. Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 12:431-441.","journal-title":"Semin. Cancer Biol."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1038\/sj.onc.1207607","volume":"23","year":"2004","unstructured":"Sall, A., et al. 2004. Mitogenic activity of Epstein-Barr virus-encoded BARF1 protein. Oncogene 23:4938-4944.","journal-title":"Oncogene"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-07-5252","volume":"68","year":"2008","unstructured":"Seto, E., T. Ooka, J. Middeldorp, and K. Takada. 2008. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. Cancer Res. 68:1030-1036.","journal-title":"Cancer Res."},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jmv.20327","volume":"76","year":"2005","unstructured":"Seto, E., et al. 2005. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J. Med. Virol. 76:82-88.","journal-title":"J. Med. Virol."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1128\/JVI.77.6.3859-3865.2003","volume":"77","year":"2003","unstructured":"Sheng, W., G. Decaussin, A. Ligout, K. Takada, and T. Ooka. 2003. Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus. J. Virol. 77:3859-3865.","journal-title":"J. Virol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.7.3066-3073.2005"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ijc.21914","volume":"119","year":"2006","unstructured":"Stevens, S. J., et al. 2006. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Int. J. Cancer 119:608-614.","journal-title":"Int. J. Cancer"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.5.4015-4021.1998"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/infdis\/175.1.38","volume":"175","year":"1997","unstructured":"Tanner, J. E., et al. 1997. Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders. J. Infect. Dis. 175:38-46.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jmb.2006.03.056","volume":"359","year":"2006","unstructured":"Tarbouriech, N., F. Ruggiero, M. de Turenne-Tessier, T. Ooka, and W. P. Burmeister. 2006. Structure of the Epstein-Barr virus oncogene BARF1. J. Mol. Biol. 359:667-678.","journal-title":"J. Mol. Biol."},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jmv.1890400215","volume":"40","year":"1993","unstructured":"van Grunsven, W. M., A. Nabbe, and J. M. Middeldorp. 1993. Identification and molecular characterization of two diagnostically relevant marker proteins of the Epstein-Barr virus capsid antigen complex. J. Med. Virol. 40:161-169.","journal-title":"J. Med. Virol."},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/infdis\/170.1.13","volume":"170","year":"1994","unstructured":"van Grunsven, W. M., W. J. Spaan, and J. M. Middeldorp. 1994. Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein. J. Infect. Dis. 170:13-19.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00007890-200201150-00019","volume":"73","year":"2002","unstructured":"Verschuuren, E. A., et al. 2002. Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication. Transplantation 73:100-104.","journal-title":"Transplantation"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2005.06.023","volume":"238","year":"2006","unstructured":"Wang, Q., et al. 2006. Anti-apoptotic role of BARF1 in gastric cancer cells. Cancer Lett. 238:90-103.","journal-title":"Cancer Lett."},{"key":"e_1_3_2_44_2","first-page":"782","volume":"23","year":"2004","unstructured":"Wang, Y., B. Luo, P. Zhao, and B. H. Huang. 2004. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma. Ai Zheng 23:782-787.","journal-title":"Ai Zheng"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1038\/sj.onc.1201128","volume":"14","year":"1997","unstructured":"Wei, M. X., M. de Turenne-Tessier, G. Decaussin, G. Benet, and T. Ooka. 1997. Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr virus. Oncogene 14:3073-3081.","journal-title":"Oncogene"},{"key":"e_1_3_2_46_2","first-page":"1843","volume":"54","year":"1994","unstructured":"Wei, M. X., J. C. Moulin, G. Decaussin, F. Berger, and T. Ooka. 1994. Expression and tumorigenicity of the Epstein-Barr virus BARF1 gene in human Louckes B-lymphocyte cell line. Cancer Res. 54:1843-1848.","journal-title":"Cancer Res."},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1099\/0022-1317-69-5-1051","volume":"69","year":"1988","unstructured":"Young, L. S., et al. 1988. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J. Gen. Virol. 69:1051-1065.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","year":"2004","unstructured":"Young, L. S., and A. B. Rickinson. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4:757-768.","journal-title":"Nat. Rev. Cancer"},{"key":"e_1_3_2_49_2","first-page":"956","volume":"46","year":"1986","unstructured":"Yu, M. C., J. H. Ho, S. H. Lai, and B. E. Henderson. 1986. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res. 46:956-961.","journal-title":"Cancer Res."},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0964-1955(94)90027-2","volume":"30","year":"1994","unstructured":"Zheng, X., L. Hu, F. Chen, and B. Christensson. 1994. Expression of Ki67 antigen, epidermal growth factor receptor and Epstein-Barr virus-encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma. Eur. J. Cancer B Oral Oncol. 30B:290-295.","journal-title":"Eur. J. Cancer B Oral Oncol."},{"key":"e_1_3_2_51_2","first-page":"2745","volume":"60","year":"2000","unstructured":"zur Hausen. A., et al. 2000. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res. 60:2745-2748.","journal-title":"Cancer Res."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00193-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00193-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:44:56Z","timestamp":1627591496000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00193-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1128\/CVI.00193-10"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00193-10","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"2010-05-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-11-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-01-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}